$Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+ -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy$

Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+ -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

Pokaži ostale verzije (1)

Bibliografski detalji
Glavni autori:	El-Mallawany, N, Geller, L, Bollard, C, Wistinghausen, B, Mussai, F, Wayne, A, Alobeid, B, Cairo, MS
Format:	Journal article
Jezik:	English
Izdano:	2011

Slični predmeti

Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy.
od: El-Mallawany, N, i dr.
Izdano: (2011)

Extensive hydroa vacciniforme
od: Hiram Larangeira de Almeida Jr, i dr.
Izdano: (2013-08-01)

Hydroa vacciniforme-like lymphoma
od: Zhang Fang, i dr.
Izdano: (2019-01-01)

Hydroa vacciniforme-like cutaneous T-cell lymphoma
od: Jian-Qiang Shi, i dr.
Izdano: (2014-01-01)

Hydroa vacciniforme lymphoproliferative disorder：a case report
od: ZHU Xia, JIN Jingjing, WANG Xin, MIAO Fei, MA Jiexian, ZHANG Jiechen, XIAO Li
Izdano: (2023-12-01)

Hydroa vacciniforme on a dark skin with mucosal involvement
od: Kelati Awatef, i dr.
Izdano: (2016-03-01)

EBV & lymphoma
od: Dolores Caballero, (Coordinating Author)
Izdano: (2019-06-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
od: Yi Tian Png, i dr.
Izdano: (2021-02-01)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
od: Qiuting Zhang, i dr.
Izdano: (2023-09-01)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
od: Mikhail Y. Salnikov, i dr.
Izdano: (2023-03-01)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
od: Ting Liu, i dr.
Izdano: (2023-06-01)

Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children
od: Agata Marjańska, i dr.
Izdano: (2024-07-01)

EBV CHRONIC INFECTIONS
od: Delia Racciatti, i dr.
Izdano: (2010-02-01)

EBV IN HODGKIN LYMPHOMA
od: Giuseppina Massini, i dr.
Izdano: (2009-11-01)

EBV CHRONIC INFECTIONS
od: Eligio Pizzigallo, i dr.
Izdano: (2010-08-01)

EBV IN HODGKIN LYMPHOMA
od: Stefan Hohaus, i dr.
Izdano: (2009-11-01)

Progress in EBV Vaccines
od: Dwain G. van Zyl, i dr.
Izdano: (2019-02-01)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
od: Darja Kanduc, i dr.
Izdano: (2020-08-01)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
od: Andrea Alberti, i dr.
Izdano: (2023-10-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
od: James P. Dugan, i dr.
Izdano: (2019-03-01)

Hydroa vacciniforme in an adult male albino: A rare case report
od: Sunil Kumar Gupta, i dr.
Izdano: (2024-05-01)

Hydroa vacciniforme-like lymphoma with systemic symptoms: Two case reports
od: Litao Wang, i dr.
Izdano: (2019-01-01)

Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells.
od: J Luis Espinoza, i dr.
Izdano: (2012-01-01)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
od: Thomas Mika, i dr.
Izdano: (2019-12-01)

EBV AND HIV-RELATED LYMPHOMA
od: Michele Bibas, i dr.
Izdano: (2009-12-01)

EBV AND HIV-RELATED LYMPHOMA
od: Andrea Antinori, i dr.
Izdano: (2009-11-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
od: ستار عبود فارس, i dr.
Izdano: (2019-05-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
od: ستار عبود فارس, i dr.
Izdano: (2019-05-01)

Roles of EBV in Haemopoetic Malignancies
od: Takahara Miki, i dr.
Izdano: (2005-12-01)

Syntropy in Children with EBV Infection
od: L.A. Khodak, i dr.
Izdano: (2015-05-01)

EBV-associated lymphoadenopathy in a child
od: H.B. Mateiko, i dr.
Izdano: (2024-12-01)

EBV-requisitioning physicians’ guess on fatigue state 6 months after acute EBV infection
od: Tarjei Tørre Asprusten, i dr.
Izdano: (2019-09-01)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
od: Marija Rozman, i dr.
Izdano: (2022-07-01)

Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
od: Qinyan Yin, i dr.
Izdano: (2017-06-01)

HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer
od: Midan Ai, i dr.
Izdano: (2008-09-01)

The EBV-MS connection: the enigma remains
od: A. van de Waterweg Berends, i dr.
Izdano: (2024-08-01)

EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes
od: Nancy Law, i dr.
Izdano: (2024-08-01)

Refractory Hydroa Vacciniforme-Like Lymphoma: Biological Insights from Morphoproteomic Analysis
od: Rohit Goswamy, i dr.
Izdano: (2022-07-01)

Adult-onset hydroa vacciniforme: A rare occurrence or a lymphoma premonition?
od: Ankita Sangwan, i dr.
Izdano: (2017-01-01)

Regulation mechanism of EBV-encoded EBER1 and LMP2A on YAP1 and the impact of YAP1 on the EBV infection status in EBV-associated gastric carcinoma
od: Yujie Sun, i dr.
Izdano: (2024-05-01)